The news story you are looking for has expired. A more recent related article is displayed below.

Ads by Google

Repros Therapeutics Secures Financing

Sep 12, 2009 (Close-Up Media via COMTEX) --

Company: Repros Therapeutics Inc (RPRX)

Repros Therapeutics announced that Repros has entered into a definitive agreement with a single institutional investor to sell 1.5 million shares of its common stock at $0.65 per share for gross proceeds of approximately $1.0 million.

In a release, the Company noted that this financing will allow Repros to continue its business activity for the near term and provide it with more flexibility to continue exploring various strategic alternatives. The offering is expected to close on or about September 11, subject to the satisfaction of customary closing conditions.

Repros Therapeutics focuses on the development of oral small molecule drugs for unmet medical needs that treat male and female reproductive disorders.

((Comments on this story may be sent to health@closeupmedia.com))

Copyright (C) 2009 Close-Up Media. All rights reserved

News Provided by COMTEX

Company: Repros Therapeutics Inc (RPRX)


Related terms: business, drugs, health, medical

Related Articles

A Three-Way Strategy on Repros Therapeutics
Oct 26, 2009
...Cap A Three-Way Strategy on Repros Therapeutics 1 comment by: optionMONSTER...Russell Options activity surged in Repros Therapeutics (RPRX) on Friday, less than...Articles A Three-Way Strategy on Repros Therapeutics Oct 26, 2009 Spectrum Pharma...

Havertys declares one-time dividend on stock
Nov 11, 2009
...time cash payment on two classes of its common stock due to recent business improvements...dividend of 2.25 cents per share on its common stock and 2 cents per share on Class A common stock, payable Dec. 11 to shareholders of...

Repros Therapeutics settles with major creditors
Oct 30, 2009
...2009, 10:27am CDT Repros Therapeutics settles with major creditors...comes on as Repros chairman Repros Therapeutics in critical condition Biopharmaceutical company Repros Therapeutics Inc. on Friday said it...

Repros Therapeutics Inc. Reports Third Quarter 2009 Financial Results - Zibb.com
Nov 9, 2009
...677,404 shares of common stock outstanding. Liquidity...million shares of our common stock at a purchase price...them shares of our common stock, at $1.10 per share...Company. About Repros Therapeutics Repros Therapeutics...